AU4677097A - Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders - Google Patents

Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders

Info

Publication number
AU4677097A
AU4677097A AU46770/97A AU4677097A AU4677097A AU 4677097 A AU4677097 A AU 4677097A AU 46770/97 A AU46770/97 A AU 46770/97A AU 4677097 A AU4677097 A AU 4677097A AU 4677097 A AU4677097 A AU 4677097A
Authority
AU
Australia
Prior art keywords
cisapride
gastro
disorders
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU46770/97A
Other versions
AU717432B2 (en
Inventor
Nancy M. Gray
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU47705/93A external-priority patent/AU4770593A/en
Application filed by Sepracor Inc filed Critical Sepracor Inc
Priority to AU46770/97A priority Critical patent/AU717432B2/en
Publication of AU4677097A publication Critical patent/AU4677097A/en
Application granted granted Critical
Publication of AU717432B2 publication Critical patent/AU717432B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU46770/97A 1992-07-07 1997-11-28 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders Ceased AU717432B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46770/97A AU717432B2 (en) 1992-07-07 1997-11-28 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90984192A 1992-07-07 1992-07-07
US909841 1992-07-07
AU47705/93A AU4770593A (en) 1992-07-07 1993-07-06 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
AU46770/97A AU717432B2 (en) 1992-07-07 1997-11-28 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU47705/93A Division AU4770593A (en) 1992-07-07 1993-07-06 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders

Publications (2)

Publication Number Publication Date
AU4677097A true AU4677097A (en) 1998-02-12
AU717432B2 AU717432B2 (en) 2000-03-23

Family

ID=25628018

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46770/97A Ceased AU717432B2 (en) 1992-07-07 1997-11-28 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders

Country Status (1)

Country Link
AU (1) AU717432B2 (en)

Also Published As

Publication number Publication date
AU717432B2 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
AU4676997A (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
EP0651639A4 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
AU674894B2 (en) Treatment of conditions and disease
AU4620789A (en) Treatment of obesity
AU7545594A (en) Implantable device for the treatment of aedemas
AU2146388A (en) Orthotic pads and methods
AU1173195A (en) Treatment of immunoregulatory disorders
AU6747887A (en) Treatment of skin disorders
AU4524889A (en) Method for the treatment of periodontal disease
AU3247593A (en) Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
AU2058697A (en) Treatment of sleep disorders
AU624067B2 (en) Preparation suitable for use in the treatment of enteric disorders
AU6386390A (en) Therapeutic necleosides
AU2806692A (en) Medicament for the treatment of anxiety
AU1279788A (en) Compounds and treatment
AU6660090A (en) Treatment of depression
AU3553489A (en) Novel compounds and treatment
AU3790489A (en) Composition and method for treatment of gastrointestinal disorders
AU2143488A (en) Use of a compound for the treatment of sleep disorders and depression
AU3999389A (en) Device for the treatment of seeds
AU8185491A (en) Treatment of disease
AU4677097A (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA947912B (en) Treatment of medical disorders associated with free radical formation
AU2297088A (en) Improved ovulation treatment
AU608865B2 (en) Treatment of cerebral disorders

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired